利用外基因组作为尖端药物输送系统,用于革命性的骨关节炎治疗
Jun Lu1, Yan Zhang1, Xinquan Yang1
1Department of Foot and Ankle Surgery, Honghui Hospital of Xi'an Jiaotong University, Xi'an City, Shaanxi Province 710054, China.
概括
外体因其自然特性而有望作为骨关节炎 (OA) 治疗的药物递送系统 (DDS). 本综述探讨了异构体的起源,机制和未来OA治疗进展的挑战.
科学领域:
- 细胞外囊泡和纳米医学
- 再生医学和生物材料
背景情况:
- 外体是细胞间通信的关键媒介.
- 它们固有的生物相容性,稳定性和低免疫性使得它们非常适合治疗应用.
- 骨关节炎 (OA) 对有效的药物输送系统 (DDS) 存在重大未满足的需求.
研究的目的:
- 为OA治疗提供基于外体的DDS的全面审查.
- 探索多样化的外体源及其治疗潜力.
- 阐明该领域的行动机制和当前挑战.
主要方法:
- 在OA治疗中对外体组研究的文献综述.
- 对外体源的分析,包括干细胞和免疫细胞.
- 检查外体细胞相互作用和治疗机制.
主要成果:
- 来自各种细胞类型的外体为OA治疗提供了独特的优势.
- 了解外体的起源和机制对于优化DDS疗效至关重要.
- 当前的挑战包括可扩展性,有针对性的交付和监管障碍.
结论:
- 基于外体的DDS代表了OA治疗的前途前沿.
- 对外体工程和临床翻译的进一步研究是有必要的.
- 合作对于克服挑战和推进OA治疗策略至关重要.
相关概念视频
01:36Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
01:19Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K